Disorders of Sex Development: Crash Course
What is DSD?
Disorders of Sex Development (DSD) are congenital conditions where chromosomal, gonadal, or anatomical sex characteristics develop atypically, affecting approximately 1% of live births 1, 2, 3. The modern terminology replaced outdated and potentially harmful terms like "intersex," "hermaphrodite," and "pseudohermaphrodite" following the 2005 Chicago Consensus 1.
Normal Sex Development: How Male and Female Differentiation Occurs
Sex development occurs in two distinct sequential processes 4, 5, 6:
1. Sex Determination (Gonadal Development)
- Undifferentiated stage: All embryos begin with identical bipotential gonads that can become either testes or ovaries 5, 7
- Genetic programming: The presence or absence of specific genes (primarily SRY on the Y chromosome) directs the bipotential gonad to differentiate into either testis or ovary 4, 6
- Critical timing: This decision occurs during a precisely timed developmental window in early embryonic life 5
- Multiple autosomal genes control both testicular and ovarian development, not just sex chromosomes 1
2. Sex Differentiation (Phenotypic Development)
- Hormone-dependent process: Once gonads form, they produce hormones that drive development of internal and external genitalia 2, 5
- Male pathway: Testes produce testosterone (masculinizes Wolffian structures into vas deferens, epididymis, seminal vesicles) and anti-Müllerian hormone (causes regression of Müllerian structures) 2, 7
- Female pathway: Ovaries allow Müllerian structures to develop into fallopian tubes, uterus, and upper vagina; Wolffian structures regress without testosterone 2
- External genitalia: Develop based on presence (male) or absence (female) of androgens 7
Classification of DSD
The Chicago Consensus established three main categories based on karyotype 1, 2:
46,XY DSD
- Testicular development disorders (gonadal dysgenesis)
- Androgen synthesis defects
- Androgen insensitivity syndromes
- Anti-Müllerian hormone defects
46,XX DSD
- Ovarian development disorders
- Androgen excess (congenital adrenal hyperplasia most common)
- Müllerian structural abnormalities
Sex Chromosome DSD
- 45,X (Turner syndrome variants)
- 47,XXY (Klinefelter syndrome)
- 45,X/46,XY mosaicism
- Ovotesticular DSD
Further classification by specific genetic defect is preferred when identified 1.
Pathophysiology Categories
Understanding the underlying mechanism guides diagnosis 7:
- Malformative DSD: Abnormal formation of genital anlagen in early embryonic development
- Dysgenetic DSD: Defects in testis differentiation causing early-onset fetal hypogonadism affecting whole testicular function (in Y chromosome patients)
- Non-dysgenetic DSD: Early-onset fetal hypogonadism affecting specifically Leydig or Sertoli cells, or end-organ hormone defects without fetal hypogonadism
Modern Management Principles
Management requires multidisciplinary teams providing individualized, lifelong care with full parental disclosure and psychosocial support 1, 8. Key shifts from historical practice include:
Core Recommendations
- Early gender assignment is still advocated, but with critical changes 1
- Surgery timing is no longer universally early: There has been a shift away from automatic equivalence of gender assignment with immediate surgery 1
- Fewer clitoroplasties are performed in less severe cases (52% of European centers reported this change) 1
- Full disclosure of all alternatives regarding surgery type and timing to families 1
- Continuing psychosocial and psychosexual care throughout the lifespan 1, 8
Diagnostic Approach
- Clinical characteristics and genital examination
- Karyotype analysis
- Hormonal measurements (baseline and stimulated)
- Imaging studies (ultrasound, MRI)
- Genetic testing for precise molecular diagnosis 2, 8
Treatment Components
- Psycho-educational counseling considering family and cultural norms 2
- Hormone therapy for pubertal induction and maintenance 8
- Surgical interventions when indicated, personalized to each case 2, 8
- Gonadal tumor risk assessment and management 8
- Fertility preservation considerations 8
- Transition planning from pediatric to adult care 8
Critical Caveats
Karyotype alone should not dictate classification or treatment because multiple autosomal genes control gonadal development, and individuals with similar karyotypes may have vastly different phenotypes 1.
The term "disorder" itself remains controversial: Some patient advocacy groups prefer "differences" or "variations" rather than "disorder," arguing these represent biological diversity rather than pathology requiring treatment 1. Sensitivity to these perspectives improves care outcomes 1.
Evidence gaps persist: Neither physician-imposed early gender assignment with surgery nor complete deferment of surgery pending patient consent has clear scientific validity 1. This necessitates transparent family counseling about uncertainties 1.
The 2009 European survey showed 100% adoption of DSD terminology, 95% providing psychological services, but only 57% regularly using multidisciplinary teams 1, indicating implementation gaps remain.